AbstractIntroductionThe purposes of this study are the characterization the lipid profile and the suitability of the statins treatment according to the cardiovascular profile. Also, in statin-treated patients, we aim to determine the prevalence of persistent lipid abnormalities.Material and methodsObservational and retrospective study of outpatient diabetic patients of a hospital consultation, between Jun/2014 and Jun/2015.ResultsOf the 199 diabetic patients included, 58.6% were treated with statins and only 13.9% were treated with statin dose adequate for its cardiovascular profile. The patients without overt cardiovascular disease had higher total cholesterol (178.0 vs 157.5mg/dl; p=0.003), HDL-C (51.0 vs 43.0mg/dl; p=0.005), LDL-C (97.0 ...
Background : As the result of the high prevalence of comorbidities and conventional risk factors amo...
Background: Data on the prevalence of dyslipidemia and attainment of goal/normal lipid levels in a S...
Background Attaining acceptable levels of LDL Cholesterol (LDL-C) significantly improves cardiovascu...
Introduction The purposes of this study are the characterization the lipid profile and the suitabil...
AbstractIntroductionThe purposes of this study are the characterization the lipid profile and the su...
Background: The prevalence of persistent lipid abnormalities in patients receiving statins in primar...
Aim To determine the prevalence and types of persistent dyslipidemia in patients treated with differ...
Aim: To determine the pattern of dyslipidemia and the extent to which lipid therapy may reduce the r...
Introduction. Considering that dyslipidaemia is an important factor for cardiovascular diseases, ta...
Aims and objectives: Diabetes is associated with the development of many cardiovascular diseases (CV...
Achieving treatment targets has been difficult in treating diabetic patients. This cross-sectional s...
Objective: This analysis of the Lipid Treatment Assessment Project 2 population compared lipid goal ...
Cardiovascular diseases (CVD) are responsible for 75% of the morbidity and mortality in patients wit...
Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins h...
Many statin-treated patients are not achieving treatment goals and are at risk of cardiovascular (CV...
Background : As the result of the high prevalence of comorbidities and conventional risk factors amo...
Background: Data on the prevalence of dyslipidemia and attainment of goal/normal lipid levels in a S...
Background Attaining acceptable levels of LDL Cholesterol (LDL-C) significantly improves cardiovascu...
Introduction The purposes of this study are the characterization the lipid profile and the suitabil...
AbstractIntroductionThe purposes of this study are the characterization the lipid profile and the su...
Background: The prevalence of persistent lipid abnormalities in patients receiving statins in primar...
Aim To determine the prevalence and types of persistent dyslipidemia in patients treated with differ...
Aim: To determine the pattern of dyslipidemia and the extent to which lipid therapy may reduce the r...
Introduction. Considering that dyslipidaemia is an important factor for cardiovascular diseases, ta...
Aims and objectives: Diabetes is associated with the development of many cardiovascular diseases (CV...
Achieving treatment targets has been difficult in treating diabetic patients. This cross-sectional s...
Objective: This analysis of the Lipid Treatment Assessment Project 2 population compared lipid goal ...
Cardiovascular diseases (CVD) are responsible for 75% of the morbidity and mortality in patients wit...
Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins h...
Many statin-treated patients are not achieving treatment goals and are at risk of cardiovascular (CV...
Background : As the result of the high prevalence of comorbidities and conventional risk factors amo...
Background: Data on the prevalence of dyslipidemia and attainment of goal/normal lipid levels in a S...
Background Attaining acceptable levels of LDL Cholesterol (LDL-C) significantly improves cardiovascu...